» Articles » PMID: 16480836

Nonmedical Use of Prescription Stimulants in the United States

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2006 Feb 17
PMID 16480836
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study estimated prevalences and correlates of stimulant diversion in the United States and examined relationships between diversion and measures of abuse or dependence.

Methods: We conducted descriptive and multivariate analysis of data from the National Survey on Drug Use and Health. Key measures were nonmedical use (misuse) of any prescription stimulant, any stimulant other than methamphetamine, and stimulants indicated for attention-deficit/hyperactivity disorder (ADHD).

Results: Lifetime stimulant misuse included some misuse of longer-acting ADHD drugs. The majority of past-year misuse involved drugs other than methamphetamine, particularly for youth aged 12-17. Past year misuse was more prevalent among persons aged 12-25, compared with older adults, and among Whites, compared with other groups. Prevalences in large metropolitan areas were lower than or similar to those in less populated areas. About 13% of past-year stimulant misusers met the survey criteria for dependence or abuse, as did about 10% of persons aged 12-25 who misused only nonmethamphetamine stimulants.

Conclusions: Most stimulant misuse in the United States (particularly among youth) involved prescription drugs other than methamphetamine. The problem is not limited to metropolitan areas.

Citing Articles

Everybody's Doing It: Initiation to Prescription Drug Misuse.

Mui H, Sales P, Murphy S J Drug Issues. 2024; 44(3):236-253.

PMID: 38318234 PMC: 10843830. DOI: 10.1177/0022042613497935.


Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.

Tan X, Xu Y, Wang S, Li J, Hu C, Chen Z Brain Sci. 2023; 13(12).

PMID: 38137075 PMC: 10742293. DOI: 10.3390/brainsci13121627.


Exploring the use of cognitive enhancement substances among Portuguese university students.

Cavaco A, Ribeiro J, Norgaard L Explor Res Clin Soc Pharm. 2022; 5:100097.

PMID: 35478516 PMC: 9032074. DOI: 10.1016/j.rcsop.2021.100097.


Associations of prescription stimulant misuse with subsequent methamphetamine use among a U.S. cohort of HIV-vulnerable sexual and gender minorities who have sex with men.

Westmoreland D, Goldshear J, Carrico A, Grov C Drug Alcohol Depend. 2021; 226:108841.

PMID: 34271513 PMC: 8358820. DOI: 10.1016/j.drugalcdep.2021.108841.


A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Nasser A, Liranso T, Adewole T, Fry N, Hull J, Busse G J Clin Psychopharmacol. 2021; 41(4):370-380.

PMID: 34181360 PMC: 8244935. DOI: 10.1097/JCP.0000000000001404.